We also observed that this trend of higher BCR centrality correlating with immunosurveillance is generalizable to noncancerous disease states, including autoimmunity (diabetes mellitus29 and multiple sclerosis30; Extended Data Fig. 5i). This evidence concerns the gene BCR and Autoimmunity.